Latest Funding News

Accelerate Resources has advanced its gold exploration at Balagundi and manganese prospects in Pilbara, bolstered by a $900,000 capital raise and a strategic joint venture at the Comet Gold Project.

Anteris Technologies Global Corp. has entered a material definitive agreement to raise approximately $320 million through a public offering and a strategic private placement with Medtronic’s subsidiary. The capital will support clinical trials and manufacturing expansion for its innovative heart valve technology.

Euroz Hartleys reports a striking 121% jump in net profit for H1 FY2026, driven by booming equity capital markets activity and rising advisory fees. The company also lifts its interim dividend, signalling confidence amid cyclical market conditions.

Falcon Metals has reported compelling high-grade gold results from its Blue Moon project in Victoria, extending mineralisation along strike and confirming the potential for a significant new gold reef. The company also advances exploration at Pyramid Hill and Errabiddy while maintaining a strong cash position.

EPX Limited has successfully raised nearly $295,000 through a Security Purchase Plan, supporting its recent acquisition of Wattwatchers and positioning the company for further expansion.

DMC Mining Limited will be delisted from the ASX on 27 January 2026 following a two-year suspension, but the company remains committed to relisting pending key exploration licences in Guinea.

Auravelle Metals has reported significant high-grade gold intersections at its Sheoak Prospect in South Australia, extending the gold trend beyond 600 metres and identifying new targets at Sheoak East. Meanwhile, early drilling at its Crown Gold Project in Western Australia confirms extensive gold anomalism, supported by a successful $2.5 million capital raise to fund ongoing exploration.

Cambium Bio has strengthened its financial footing with a $0.6 million R&D tax refund and a $2.4 million strategic placement, setting the stage for pivotal Phase 3 clinical trials of its lead ophthalmology candidate.

Sky Metals has launched a major drilling campaign at its Tallebung Tin Project, aiming to expand high-grade resources and update its Mineral Resource Estimate. Meanwhile, a metallurgical breakthrough at Doradilla confirms its potential as a second key tin asset.

Ballard Mining has raised $61 million through a well-supported placement to fund an aggressive drilling program and early development works at its Mt Ida Gold Project, positioning the company for a Final Investment Decision.

Strickland Metals has announced a maiden inferred resource of 1.2 million ounces of gold at its Gradina Deposit, lifting the total Rogozna Project resources by 16% to 8.6 million ounces gold equivalent. The company plans an ambitious 60,000-metre drilling campaign in 2026 to further expand and define its Serbian gold-base metals assets.

Nyrada Inc. has secured ethics approval to launch a Phase IIa clinical trial for its heart attack drug Xolatryp®, with patient recruitment set for March 2026. The company maintains a solid cash position of AU$7.12 million as it expands its research into oncology.